📌 Key Takeaways
- Topic: Silica for Feed Carrier: How It Carries Vitamins and Liquids in Animal Feed
- Keywords: PPG Hi-Sil
- Published: 2026-11-20 02:53:25
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Cabot Cab-O-Sil: Product Range, Key Grades and Alternatives
- Silica Distributor vs Manufacturer: Which Is Better for Your Purchase?
- Auzel, F. Upconversion and anti-stokes processes with f and d ions in solids. Chem. Rev. 104, 139-174 (2004). Post CAS PubMed Google Scholar
- Matting Agent for Coatings: Types, Selection Guide and Performance Comparison
- Alumina Powder vs Silica Powder: Properties, Uses and How to Choose
- H.L. and R.S. conceived and revised the paper, B.X. drew the figures and wrote the paper, S.L. collected the data and wrote the paper. All the authors have read and approved the paper.
- BET Surface Area of Silica: Measurement Method and Typical Values by Grade
- Li, X., Kwon, N., Guo, T., Liu, Z. & Yoon, J. Innovative tactics for hypoxic‐tumor photodynamic therapy. Angew. Chem. Int. Ed. 57, 11522-11531 (2018). Article CAS Google Scholar
Spherical Silica Manufacturer: Key Capabilities, Purity Control and Selection Criteria
What is silica (SiO₂)?
E551
What is the difference between fumed silica and precipitated silica?
silica filler for CCL Xuan, M. et al. Magnetic mesoporous silica nanoparticles cloaked by red blood cell membranes: applications in cancer therapy. Angew. Chem. Int. Ed. 57, 6049-6053 (2018). Post CAS Google Scholar
What drives silica raw material prices?
quartz CAS 14808-60-7 Immunotherapy is a therapeutic approach implemented using the immune system of biological organisms, and can be carried out by activating or suppressing the immune system. 438, 439 The most common application is cancer immunotherapy. 440, 441 In cancer therapy, immunotherapeutic agents such as tumor-associated antigens or immune adjuvants are often used to educate antigen-presenting cells and T cells, thus to enhance the host immune response to cancer. However, it remains a difficulty to improve the delivery efficiency of immunotherapeutic agents, to steer clear of dose-dependent toxicity, and to mitigate immune-mediated adverse impacts. 438, 439 In this regard, MSNs have emerged as a perfect multifunctional platform for improving immunotherapy because of their excellent porosity, good biocompatibility and ease of surface modification. 30, 31 In MSNs-based immunotherapy, MSNs can play a role in different periods of the cancer immune cycle. 31 For example, chemokine-loaded MSNs promote T-cell tumor chemotaxis, 442 MSNs-based platforms regulate the immune checkpoint proteins, 443 MSNs loaded with chemotherapeutic drugs, 444 photosensitizers, 445 sonosensitizers 446 or PTAs 447 induce immunogenic cell death (ICD), and MSNs as vaccine vehicles are employed to deliver antigens and adjuvants. In particular, MSNs themselves can serve as effective adjuvants, and contribute to the recruitment and activation of immune cells. 448, 449, 450 At present, there has been considerable progress in MSNs-based immunotherapy platforms. A few recent studies are presented as brief instances. Large-pore MSNs-coated upconversion NPs are used as immune adjuvants to deliver photosensitizers merocyanine 540, model proteins, and tumor antigens for synergistic photodynamic immunotherapy of cancer. 122 The diselenide-bridged organic MSNs loaded with chemotherapeutic ruthenium compound were acted as potential ICD nanoamplifiers for improved cancer chemo-immunotherapy. 451 Au, BP co-loaded MSNs modified with macrophage cell membrane were applied to deliver CO precursor for enhancing SDT-induced ICD impact and inhibiting the expansion and metastasis of breast tumor. 446
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.